FidoCure®
Case Studies
8 posts with this tag
Thyroid Carcinoma Case Study: Lulu
After more than 20 months of FidoCure® enabled treatment, Lulu has remained free from further metaseses. There has been no evidence of disease recurrence or pulmonary metastasis. Lulu has maintained a positive quality of life while in treatment and achieved extended time with her pet owners.
Case StudiesHemophagocytic Histiocytic Sarcoma Case Study: Forrest Lau
A 11 yr old Golden with hemophagocytic histiocytic sarcoma, 38 months in remission. FidoCure® identified a rare tumor suppressor mutation and suggested additional therapy that may have helped target tumor cells.
Lung Carcinoma Case Study: Adley Hurwitz
After six months of FidoCure® enabled therapy, Adley showed no evidence of pulmonary mass recurrence.
Case StudiesSquamous Cell Carcinoma Case Study: Duchess Thornhill
It is clear that the utilization of targeted therapy has proven beneficial in improving patient quality of life, extending survival time with minimal disease progression, and having an overall positive impact on patient care.
Case StudiesMammary Carcinoma Case Study: Missy Martino
After one year of FidoCure®targeted therapy, Missy showed no evidence of pulmonary metastatic disease.
Case StudiesTCC Case Study: Sir Oliver
Sir Oliver, an 8 year old French Bulldog with TCC, is surviving and thriving thanks to his targeted therapeutic treatment4.5 months from FidoCure™ enrollment, Sir Oliver's latest CT scan showed a 38% reduction in his bladder tumor.
Case StudiesSoft Tissue Sarcoma Case Study: Gracie Gonzales
After FidoCure® enabled treatment, there was a significant reduction in the size of the primary lesion and complete resolution of thoracic metastasis.
